A Study of ZL-1310 in Participants With Selected Solid Tumors
NCT06885281 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 112
Last updated 2026-05-08
Summary
A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors
Conditions
Interventions
- DRUG
-
ZL-1310
drug ZL-1310
Sponsors & Collaborators
-
Zai Lab (US) LLC
collaborator INDUSTRY -
Zai Lab (Shanghai) Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-12
- Primary Completion
- 2027-08-31
- Completion
- 2027-12-31
- FDA Drug
- Yes
Countries
- United States
- China
Study Locations
More Related Trials
-
A Study YL201 in Patients With Selected Advanced Solid Tumors
NCT06057922 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of ZG005 in Patients With Advanced Solid Tumors
NCT06927687 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase 1b Study of ZN-c3 in Chinese Subjects
NCT04972422 ·Status: UNKNOWN ·Phase: PHASE1
-
SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)
NCT04291079 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of BL-B16D1 in Patients With Locally Advanced or Metastatic Solid Tumors
NCT06475131 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors
NCT05170958 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
NCT03734913 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Study of SM3321 With Solid Tumors
NCT06087770 ·Status: RECRUITING ·Phase: PHASE1
-
Phase I/II Clinical Trial of LBL-015 for Injection
NCT05107011 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of YL202 in Selected Patients With Advanced Solid Tumors
NCT06107686 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of ZG005 in Patients With Advanced Solid Tumors
NCT06233292 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor
NCT06239298 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase I Study of XZ120 in Malignant Tumors
NCT06206915 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
NCT07105215 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma
NCT02801487 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Phase Ib Study of Primary Efficacy and Safety of IBI321 Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors
NCT05172856 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of ZGGS18 in Patients With Advanced Solid Tumors
NCT05584800 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutation
NCT05173805 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
NCT05956587 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (Gynecological Tumors)
NCT06145802 ·Status: WITHDRAWN ·Phase: NA
-
A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
NCT05923008 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
NCT05803018 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx
NCT06611137 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors
NCT05779163 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Trail Evaluating Carbon Ion Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma
NCT02569788 ·Status: TERMINATED ·Phase: PHASE1/PHASE2